AI Article Synopsis
Article Abstract
Objective: To examine the morphology of endometrium in women who failed to conceive after nine or more cycles of donor insemination treatment.
Design: Prospective study.
Setting: Jessop Hospital for Women, Sheffield.
Subjects: Two groups: twenty-six infertile women and a control group of eight fertile women.
Intervention: Endometrial biopsy specimens were obtained in the mid-luteal phase, timed precisely by the luteinising hormone surge.
Main Outcome Measure: Morphological study of endometrial biopsy specimens by the use of traditional dating criteria and established morphometric techniques.
Results: Twelve biopsy specimens (42%) were found to be retarded. In addition, morphometric analysis revealed significant differences in the glandular component of the endometrium between the infertile and fertile groups.
Conclusion: Endometrial defect leading to implantation failure may be an important underlying cause of failure to conceive after repeated attempts at donor insemination. The endometrium should be investigated in this group of women, and further attempts at donor insemination treatment should be offered only in conjunction with attempts to restore the normality of the endometrium.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1471-0528.1993.tb15111.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pregnancy complicated by fetal goiter following lung transplantation for idiopathic pulmonary arterial hypertension: A case study.
Taiwan J Obstet Gynecol
January 2025
Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Objective: We report a case of pregnancy following lung transplantation (LT) for idiopathic pulmonary arterial hypertension (IPAH) in Japan.
Case Report: A female developed IPAH at 14 years of age and underwent a successful bilateral living-donor lobar LT from her parents at 19 years of age (gravida 2, para 0). At the age of 40 years, the patient became pregnant via artificial insemination.
Patterns of utilization of advanced practice providers in reproductive endocrinology: a 2023 national survey.
F S Rep
December 2024
Ferring Pharmaceuticals Inc., Parsippany, New Jersey.
Objective: To evaluate the current utilization of advanced practice providers (APPs) within the field of reproductive endocrinology and infertility.
Design: Cross-sectional.
Setting: Web-based.
[Study of the feasibility of polar body transfer combined with preimplantation genetic testing for blocking the intergenerational transmission of mitochondrial genetic diseases].
Zhonghua Yi Xue Yi Chuan Xue Za Zhi
January 2025
Reproductive Medicine Center, Department of Obstetrics and Gynecology, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, China.
Objective: To assess the feasibility of first polar body transfer (PB1T) combined with preimplantation mitochondrial genetic testing for blocking the transmission of a pathogenic mitochondrial DNA 8993T>G mutation.
Methods: A Chinese family affected with Leigh syndrome which had attended the Reproductive Medicine Centre of the First Affiliated Hospital of Anhui Medical University in September 2021 was selected as the study subject. Controlled ovarian hyperstimulation was carried out for the proband after completing the detection of the mitochondrial DNA 8993T>G mutation load among the pedigree members.
A case of assisted reproductive technology-induced maternal alloimmunization: an emerging sensitizing factor to consider?
Immunohematology
December 2024
Transfusion Medicine, Dr. Rela Institute & Medical Centre, Bharath Institute of Higher Education and Research, Chennai, Tamilnadu, India.
Red blood cell (RBC) alloimmunization can occur because of exposure to various sensitizing factors and poses a constant threat in transfusion. Assisted reproductive technology (ART) involves manipulation of sperm, ova, or embryos with the goal of producing a pregnancy. We present an interesting case of ART-induced maternal alloimmunization (AIMA) due to anti-c in a woman carrying a twin pregnancy.
View Article and Find Full Text PDFMaternal Morbidity and Medically Assisted Reproduction Treatment Types.
Obstet Gynecol
February 2025
Centre for Longitudinal Studies, Social Research Institute, University College London, London, United Kingdom; Population Science, Huntsman Cancer Institute, the Department of Family and Consumer Studies, the Department of Obstetrics and Gynecology, and the Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City; Max Planck Institute for Demographic Research, Rostock, Germany; the Helsinki Institute for Demography and Population Health, University of Helsinki, Helsinki, Finland; and the Max Planck - University of Helsinki Center for Social Inequalities in Population Health, Rostock, Germany and Helsinki, Finland.
Article Synopsis
- The study aims to analyze the risk of maternal morbidity based on how pregnancies were achieved, focusing on various methods of medically assisted reproduction like fertility drugs, IUI, and ART.
- Data from Utah's birth certificates (2009-2017) showed that 4.8% of pregnancies were from assisted reproduction, with maternal morbidity defined by complications like blood transfusions and ICU admissions.
- Results indicated higher maternal morbidity risks for those using assisted reproduction, particularly with ART and autologous oocytes, although these risks decreased when controlling for factors like multiple pregnancies and existing health issues.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!